Method of mitigating the adverse effects of IL-2

Details for Australian Patent Application No. 2004244987 (hide)

International Classifications

Event Publications

15 December 2005 PCT application entered the National Phase

PCT publication WO2004/108077 Priority application(s): WO2004/108077

2 March 2006 Change of Name(s) of Applicant(s), Section 104

BioMedicines, Inc. The name of the applicant has been changed to Intarcia Therapeutics, Inc.

3 April 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.